STEMI as the Initial Presentation of Polyarteritis Nodosa Associated with Hepatitis B: A Rare Cardiovascular Manifestation
A. MOUNSSIF *
CHU Ibn Rochd, Morocco.
B. ELKABLI
CHU Ibn Rochd, Morocco.
Z. MOULAY RCHID
CHU Ibn Rochd, Morocco.
M. BOUZIANE
CHU Ibn Rochd, Morocco.
M. HABOUB
CHU Ibn Rochd, Morocco.
S. AROUS
CHU Ibn Rochd, Morocco.
EM. BENOUNA
CHU Ibn Rochd, Morocco.
A. DRIGHIL
CHU Ibn Rochd, Morocco.
R. HABBAL
CHU Ibn Rochd, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Background: Polyarteritis nodosa (PAN) is a rare necrotizing vasculitis affecting medium-sized arteries. While cardiac involvement is uncommon, it can lead to severe coronary complications. We report a case of hepatitis B virus-associated PAN (PAN-HBV) revealed by an acute ST-elevation myocardial infarction (STEMI).
Case Presentation: A 49-year-old male smoker presented with anterior STEMI. Echocardiography revealed severe left ventricular dysfunction and an apical thrombus. Coronary angiography showed multiple aneurysmal dilatations and critical stenoses. Hepatitis B serology was positive, with no other infectious or autoimmune findings. PAN-HBV was diagnosed. The patient underwent percutaneous coronary intervention (PCI) and was treated with dual antiplatelet therapy, antivirals (tenofovir), and a short course of corticosteroids.
Discussion: This case underscores the need to consider vasculitis in young patients with atypical coronary lesions, combining stenoses and aneurysms. The angiographic findings were key to the diagnosis. Prompt antiviral therapy and cautious immunosuppression were critical in managing both the ischemic event and underlying vasculitis.
Conclusion: PAN-HBV can manifest initially as an acute coronary syndrome, particularly STEMI, without systemic features of vasculitis. Early recognition and a multidisciplinary approach are essential for optimizing outcomes in these patients.
Keywords: Polyarteritis nodosa, Hepatitis B virus (HBV), ST-elevation myocardial infarction (STEMI), coronary artery aneurysm, coronary angioplasty, drug-eluting stent, vasculitis, heart failure